MedWellAI Inc. MWAI
—
0.34
0.00
0.00%
as of 25 Sep
- Market cap
- —
- P/E
- 0.0×
Follow MWAI
| Older periods | Jun '25 | Sep '25 | Dec '25 | Mar '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
69.86% | 52.51% | 42.51% | 35.89% | |
| (151.94%) | (152.63%) | (162.15%) | (208.51%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
139.00% | 42.00% | 35.57% | 30.49% | |
Average Days of Receivables |
0.18 | 0.00 | 0.00 | 0.74 | |
Free Cash Flow per Share |
0.05 | (0.09) | (0.10) | 0.02 | |
Free Cash Flow |
0.31 | (0.54) | (0.64) | 0.11 | |
Capital Expenditures |
1.16 | 0.23 | — | 0.48 | |
Piotroski F-Score |
3.00 | 2.00 | 2.00 | 2.00 | |
| Other line items | |||||
Cash ROIC |
43.87% | 226.70% | 98.26% | 41.61% | |
Accounts Receivable Turnover |
77.74 | 0.00 | 0.00 | 622.83 | |
Accounts Payable Turnover |
0.06 | 0.00 | 0.79 | 8.27 | |
Inventory Turnover |
0.00 | — | 0.00 | 0.00 | |
Average Days of Payables |
5,569.63 | 0.00 | 69.16 | 27.75 | |
Days of Inventory on Hand |
0.00 | — | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
440.44% | 391.17% | 226.74% | 119.94% | |
Share Based Compensation of Revenue |
100.81% | 94.07% | 59.35% | 10.88% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.24 | 0.25 | 0.24 | 0.16 | |
Depreciation/Fixed assets |
0.76 | 0.80 | 0.79 | 0.73 | |
Capex/Depreciation |
36.21 | 6.22 | 0.00 | 15.49 | |
Revenue per Share |
0.10 | 0.11 | 0.17 | 0.23 | |
Operating CF per Share |
(0.15) | (0.13) | (0.10) | (0.06) | |
Capex per Share |
0.20 | 0.04 | 0.00 | 0.08 | |
Capex to Sales |
(1.94) | (0.34) | 0.00 | (0.33) | |
Net Profit Margin |
(606.54%) | (441.21%) | (242.59%) | (161.13%) |
Columns are period end dates